Development of a capillary electrophoresis method for the assay of ramipril and its impurities: An issue of cis-trans isomerization

Journal of Chromatography A

Volumn 1218, Issue 18, 2011, Pages 2611-2617

  Orlandini, Serena ^a   Gotti, Roberto ^b   Giannini, Iacopo ^a   Pasquini, Benedetta ^a   Furlanetto, Sandra ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Capillary electrophoresis; Cis trans isomerization; Experimental design; Impurities; Ramipril

Indexed keywords

AMIDE BOND; ANALYTES; ANALYTICAL PARAMETERS; BACK GROUND ELECTROLYTE; BASELINE SEPARATION; CIS-TRANS; CIS-TRANS ISOMER; CIS-TRANS ISOMERIZATION; ELECTROPHEROGRAMS; ELECTROPHORETIC MIGRATION; EXPERIMENTAL CONDITIONS; EXPERIMENTAL DESIGN; IMPURITIES IN; INTERCONVERSIONS; MICROEMULSION ELECTROKINETIC CHROMATOGRAPHY; N-BUTANOL; N-HEPTANES; OPTIMISED CONDITIONS; PHARMACEUTICAL DOSAGE FORMS; PSEUDO-STATIONARY PHASIS; RAMIPRIL; REAL SAMPLES; REVERSE POLARITY;

AMIDES; AMINO ACIDS; CAPILLARY ELECTROPHORESIS; CHROMATOGRAPHY; DESIGN; DRUG PRODUCTS; ELECTROCHEMISTRY; ISOMERIZATION; MICROEMULSIONS; STATISTICS;

ISOMERS;

BUTANOL; DODECYL SULFATE SODIUM; FLUFENAMIC ACID; HEPTANE; PHOSPHATE; RAMIPRIL;

ACCURACY; ARTICLE; CAPILLARY ELECTROPHORESIS; CONTROLLED STUDY; DRUG IDENTIFICATION; DRUG IMPURITY; DRUG STRUCTURE; ELECTROPHORETIC MOBILITY; ISOMERIZATION; MICROEMULSION ELECTROKINETIC CHROMATOGRAPHY; PRIORITY JOURNAL; PROCESS DEVELOPMENT; PROCESS OPTIMIZATION; QUANTITATIVE ANALYSIS; TABLET;

DRUG CONTAMINATION; ELECTROPHORESIS, CAPILLARY; ISOMERISM; MULTIVARIATE ANALYSIS; RAMIPRIL; REGRESSION ANALYSIS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 79954416314     PISSN: 00219673     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.chroma.2011.02.062     Document Type: Article

References (54)

1. Sweetman S.C. Martindale: The Complete Drug Reference 2007, Pharmaceutical Press, London. 35th ed.
2. European Pharmacopoeia 6.0, vol. 2, Council of Europe, Strasbourg, 2008, p. 2807.
3. Bonazzi D., Gotti R., Andrisano V., Cavrini V. J. Pharm. Biomed. Anal. 1997, 16:431.
4. Abdellatef H.E., Ayad M.M., Taha E.A. J. Pharm. Biomed. Anal. 1999, 18:1021.
5. Al-Majed A.A., Al-Zehouri J. Farmaco 2001, 56:291.
6. Ayad M.M., Shalaby A.A., Abdellatef H.E., Hosny M.M. J. Pharm. Biomed. Anal. 2002, 28:311.
7. El Yazbi F.A., Mahrous M.E., Hammoud H.H., Sonji G.M., Sonji N.M. Anal. Lett. 2008, 41:853.
8. Elazazy M.S., El-Mammli M.Y., Shalaby A., Ayad M.M. Chem. Anal. - Warsaw 2008, 53:725.
9. Al-Majed A.A., Belal F., Abadi A., Al-Obaid A.M. Farmaco 2000, 55:233.
10. Belal F., Al-Zaagi I.A., Abounassif M.A. J. AOAC Int. 2001, 84:1.
11. Emara S., El-Gindy A., El-Shorbagi A.N., Hadad G. Anal. Chim. Acta 2003, 489:115.
12. Bhushan R., Gupta D., Singh S.K. Biomed. Chromatogr. 2006, 20:217.
13. Gupta K.R., Wankhedet S.B., Tajne M.R., Wadodkar S.G. Asian J. Chem. 2007, 19:4177.
14. Manna L., Valvo L., Alimonti S. Chromatographia 2001, 53:271.
15. Belal F., Al-Zaagi I.A., Gadkariem E.A., Abounassif M.A. J. Pharm. Biomed. Anal. 2001, 24:335.
16. Patil K.R., Rane V.P., Sangshetti J.N., Shinde D.B. Chromatographia 2008, 67:575.
17. Persson B.A., Fakt C., Ervik M., Ahnoff M. J. Pharm. Biomed. Anal. 2006, 40:794.
18. Zhu Z.M., Vachareau A., Neirinck L. J. Chromatogr. B 2002, 779:297.
19. Lu X.Y., Shen-Tu J.-Z., Liu J. J. Pharm. Biomed. Anal. 2006, 40:478.
20. Gowda K.V., Mandal U., Selvan P.S., Solomon W.D.S., Ghosh A., Sarkar A.K., Agarwal A., Rao T.N., Pal T.K. J. Chromatogr. B 2007, 858:13.
21. Yuan B., Wang X., Zhang F.E., Jia J., Tang F.L. Chromatographia 2008, 68:533.
22. Aboulenein H.Y., Thiffault C. Anal. Lett. 1991, 24:2217.
23. Hogan B.L., Williams M., Idiculla A., Veysoglu T., Parente E. J. Pharm. Biomed. Anal. 2000, 23:637.
24. The United States Pharmacopeia, 32nd Rev., vol. 3, The United States Pharmacopeial Convention, Rockville, 2009, p. 3474.
25. Jouyban A., Kenndler E. Electrophoresis 2008, 29:3531.
26. Gotti R., Andrisano V., Cavrini V., Bertucci C., Furlanetto S. J. Pharm. Biomed. Anal. 2000, 22:423.
27. Hillaert S., Van den Bossche W. J. Chromatogr. A 2000, 895:33.
28. Hillaert S., De Grauwe K., Van den Bossche W. J. Chromatogr. A 2001, 924:439.
29. Hillaert S., Vander Heyden Y., Van den Bossche W. J. Chromatogr. A 2002, 978:231.
30. Poole C.F. The Essence of Chromatography 2003, Elsevier, Amsterdam.
31. Moore A.W., Jorgenson J.W. Anal. Chem. 1995, 67:3464.
32. Ma S., Kálmán F., Kálmán A., Thunecke F., Horváth C. J. Chromatogr. A 1995, 716:167.
33. Thunecke F., Kálmán A., Kálmán F., Ma S., Rathore A.S., Horváth C. J. Chromatogr. A 1996, 744:259.
34. Rathore A.S., Horváth C. Electrophoresis 1997, 18:2935.
35. Schoetz G., Trapp O., Schurig V. Electrophoresis 2001, 22:2409.
36. Stellwagen E., Ledger R. Anal. Biochem. 2003, 321:167.
37. Trapp O., Trapp G., Schurig V. Electrophoresis 2004, 25:318.
38. Newman C.I.D., McGuffin V.L. Electrophoresis 2006, 27:542.
39. Meyer S., Jabs A., Schutkowski M., Fischer G. Electrophoresis 1994, 15:1151.
40. Lewis G.A., Mathieu D., Phan-Tan-Luu R. Pharmaceutical Experimental Design 1999, Marcel Dekker, New York.
41. Cornell J.A. Experiments and Mixtures. Designs, Models and the Analysis of Mixture Data 1990, J. Wiley & Sons, New York. second ed.
42. ICH Harmonised Tripartite Guideline, Q2(R1), Validation of Analytical Procedures: Text and Methodology, 2005.
43. D. Mathieu, J. Nony, R. Phan-Tan-Luu, NEMROD-W, LPRAI sarl, Marseille.
44. Furlanetto S., Orlandini S., Marras A.M., Mura P., Pinzauti S. Electrophoresis 2006, 27:805.
45. Giannini I., Orlandini S., Gotti R., Pinzauti S., Furlanetto S. Talanta 2009, 80:781.
46. Orlandini S., Giannini I., Villar Navarro M., Pinzauti S., Furlanetto S. Electrophoresis 2010, 31:3296.
47. Furlanetto S., Orlandini S., Giannini I., Pasquini B., Pinzauti S. Talanta 2010, 83:72.
48. Furlanetto S., Pinzauti S., La Porta E., Chiarugi A., Mura P., Orlandini S. J. Pharm. Biomed. Anal. 1998, 17:1015.
49. Massart D.L., Vandeginste B.G.M., Buydens L.M.C., De Jong S., Lewi P.J., Smeyers- Verbeke J. Handbook of Chemometrics and Qualimetrics. Part A 1997, Elsevier, Amsterdam.
50. Mathieu D., Phan-Tan-Luu R., Sergent M. Criblage et Etude des Facteurs 1996, LPRAI, Marseille.
51. Ferreira S.L.C., Bruns R.E., Ferreira H.S., Matos G.D., David J.M., Brandão G.C., da Silva E.G.P., Portugal L.A., dos Reis P.S., Souza A.S., dos Santos W.N.L. Anal. Chim. Acta 2007, 597:179.
52. Furlanetto S., Orlandini S., Giannini I., Beretta G., Pinzauti S. Electrophoresis 2009, 30:633.
53. Gustafsson S., Eriksson B.M., Nilsson I. J. Chromatogr. 1990, 506:75.
54. J. Ermer, J.H.McB. Miller (Eds.), Method Validation in Pharmaceutical Analysis-A Guide to Best Practice, Wiley-VCH, Weinheim, 2004.